Nordic Capital to take majority share in corpuls

• corpuls’ founding family will be represented on the management board
• The transaction is expected to be completed at the end of Q2 or the beginning of Q3 2023
• Nordic Capital is a private equity investor headquartered in Stockholm, Sweden

Nordic Capital will acquire a majority share in corpuls, a medical technology company that provides emergency medical services and cardiac resuscitation, in partnership with the founding family.

corpuls is headquartered in Kaufering, Germany. The company reported revenues of €127 million in 2022 and employs 450 people.

corpuls’ founding family is in a long-term partnership with Nordic Capital and will remain invested in the company and represented on the management board, according to a release.

Nordic’s investment will further expand corpuls’ international footprint.

Nordic’s other investments include The Binding Site, Equashield, Advanz Pharma, and Sunrise Medical.

“With this transaction, Nordic Capital is further strengthening its footprint as a partner to support innovative, mid-sized growth companies in the important German-speaking region,” said Rainer Lenhard, partner, and head of DACH, Nordic Capital Advisors.

The transaction is expected to be completed at the end of Q2 or the beginning of Q3 2023, subject to relevant regulatory approvals.

Nordic Capital is a private equity investor headquartered in Stockholm, Sweden. The firm has invested €22 billion in over 130 investments.